Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model

Pulmonary arterial hypertension (PAH) is a rare but fatal disease characterized by elevated pulmonary vascular resistance and increased pressure in the distal pulmonary arteries. Systematic analysis of the proteins and pathways involved in the progression of PAH is crucial for understanding the underlying molecular mechanism. In this study, we performed tandem mass tags (TMT)-based relative quantitative proteomic profiling of lung tissues from rats treated with monocrotaline (MCT) for 1, 2, 3 and 4 weeks. A total of 6759 proteins were quantified, among which 2660 proteins exhibited significant changes (p-value < 0.05, fold change < 0.83 or >1.2). Notably, these changes included several known PAH-related proteins, such as Retnla (resistin-like alpha) and arginase-1. Furthermore, the expression of potential PAH-related proteins, including Aurora kinase B and Cyclin-A2, was verified via Western blot analysis. In addition, we performed quantitative phosphoproteomic analysis on the lungs from MCT-induced PAH rats and identified 1412 upregulated phosphopeptides and 390 downregulated phosphopeptides. Pathway enrichment analysis revealed significant involvement of pathways such as complement and coagulation cascades and the signaling pathway of vascular smooth muscle contraction. Overall, this comprehensive analysis of proteins and phosphoproteins involved in the development and progression of PAH in lung tissues provides valuable insights for the development of potential diagnostic and treatment targets for PAH.

[1]  W. Xie,et al.  Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization , 2022, Oxidative medicine and cellular longevity.

[2]  M. Humbert,et al.  Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension , 2021, International journal of molecular sciences.

[3]  Lingfei Li,et al.  Microtubule associated protein 4 (MAP4) phosphorylation reduces cardiac microvascular density through NLRP3-related pyroptosis , 2021, Cell death discovery.

[4]  Dana R. Valley,et al.  A proteogenomic portrait of lung squamous cell carcinoma , 2021, Cell.

[5]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[6]  Yuan Zhang,et al.  Profiling and Molecular Mechanism Analysis of Long Non-Coding RNAs and mRNAs in Pulmonary Arterial Hypertension Rat Models , 2021, Frontiers in Pharmacology.

[7]  J. Leopold,et al.  Integrative Omics to Characterize and Classify Pulmonary Vascular Disease. , 2021, Clinics in chest medicine.

[8]  Md Khadem Ali,et al.  Novel Advances in Modifying BMPR2 Signaling in PAH , 2020, Genes.

[9]  Liang-di Xie,et al.  Transcriptomic analysis identifies Toll‐like and Nod‐like pathways and necroptosis in pulmonary arterial hypertension , 2020, Journal of cellular and molecular medicine.

[10]  J. Elinoff,et al.  How low should we go? Potential benefits and ramifications of the pulmonary hypertension hemodynamic definitions proposed by the 6th World Symposium. , 2020, Current opinion in pulmonary medicine.

[11]  A. Malik,et al.  Plasmalemmal Vesicle Associated Protein (PV1) in Caveolae Controls Lung Endothelial Permeability. , 2020, American journal of respiratory cell and molecular biology.

[12]  Jeffrey R. Whiteaker,et al.  Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma , 2020, Cell.

[13]  Hongmei Wu,et al.  Protein expression profile changes of lung tissue in patients with pulmonary hypertension , 2020, PeerJ.

[14]  F. Cheng,et al.  Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension , 2019, Scientific Reports.

[15]  R. Johns,et al.  HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Cross Talk in Pulmonary Hypertension. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Guo Ci Teo,et al.  Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma , 2019, Cell.

[17]  Li Zhang,et al.  Revealing the pathogenic changes of PAH based on multiomics characteristics , 2019, Journal of Translational Medicine.

[18]  Lingfei Li,et al.  Phosphorylation of Microtubule- Associated Protein 4 Promotes Hypoxic Endothelial Cell Migration and Proliferation , 2019, Front. Pharmacol..

[19]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[20]  W. Chung,et al.  Genetics and genomics of pulmonary arterial hypertension , 2019, European Respiratory Journal.

[21]  Traci L. Marin,et al.  AMP‐activated Protein Kinase Phosphorylation of Angiotensin‐Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension , 2018, American journal of respiratory and critical care medicine.

[22]  M. Humbert,et al.  Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension , 2018, The Journal of clinical investigation.

[23]  M. Nishimura,et al.  Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension , 2017, Medicine.

[24]  M. Humbert,et al.  Epidemiology and treatment of pulmonary arterial hypertension , 2017, Nature Reviews Cardiology.

[25]  N. Morrell,et al.  HIF2α–arginase axis is essential for the development of pulmonary hypertension , 2016, Proceedings of the National Academy of Sciences.

[26]  B. Dahal,et al.  Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis , 2015, European Respiratory Journal.

[27]  J. Garcia,et al.  Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[28]  M. Capecchi,et al.  Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension , 2014, Nature Medicine.

[29]  Nadia Hedhli,et al.  Cardiovascular effects of neuregulin-1/ErbB signaling: role in vascular signaling and angiogenesis. , 2014, Current pharmaceutical design.

[30]  T. Henriques-Coelho,et al.  Cellular interplay in pulmonary arterial hypertension: implications for new therapies. , 2014, Biochimica et biophysica acta.

[31]  M. Humbert,et al.  Pathogenesis of pulmonary arterial hypertension: lessons from cancer , 2013, European Respiratory Review.

[32]  R. Dweik,et al.  Causes and circumstances of death in pulmonary arterial hypertension. , 2013, American journal of respiratory and critical care medicine.

[33]  J. Wharton,et al.  Proteomic Analysis of Lung Tissues From Patients With Pulmonary Arterial Hypertension , 2010, Circulation.

[34]  J. Siamwala,et al.  eNOS phosphorylation in health and disease. , 2010, Biochimie.

[35]  R. Stan,et al.  PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. , 2004, Molecular biology of the cell.

[36]  M. Humbert,et al.  Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[37]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[38]  J. Ross,et al.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Christ,et al.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.

[40]  R. Trembath,et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.

[41]  G. Palade,et al.  PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[43]  Haiyang Tang,et al.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension. , 2021, Advances in experimental medicine and biology.